88 results on '"Niebroj-Dobosz I"'
Search Results
2. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
3. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes
4. Motor unit hyperexcitability in amyotrophic lateral sclerosis vs amino acids acting as neurotransmitters
5. Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis
6. Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients
7. Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS)
8. Altered distribution of lamin and emerin in muscle nuclei of sIBM patients
9. Elevated calmodulin levels and reduced calmodulin-stimulated calcium-ATPase in Duchenne progressive muscular dystrophy
10. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
11. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
12. Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients
13. Altered distribution of lamin and emerin in muscle nuclei of sIBM patients
14. Identification of Gal(β1-3)GalNAc bearing glycoproteins in cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients
15. Osteopontin ? a fibrosis-related marker ? in dilated cardiomyopathy in patients with Emery-Dreifuss muscular dystrophy.
16. Serum cholinesterase activity in infantile and juvenile spinal muscular atrophy.
17. Proteins of muscle subcellular fractions in Duchenne progressive muscular dystrophy stained with 'Stains-all' cationic carbocyanine dye and with Coomassie blue.
18. DISTURBANCES OF THE COMBUSTION PROCESSES IN MUSCULAR DISORDERS.
19. Elevated calmodulin levels and reduced calmodulinstimulated calciumATPase in Duchenne progressive muscular dystrophy
20. Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods
21. Evidence for autoimmunity to heart-specific antigens in patients with Emery-Dreifuss muscular dystrophy
22. Circulating autoantibodies to troponin I in Emery-Dreifuss muscular dystrophy
23. Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS)
24. Influence of aging on the protein profile of myelin isolated from human brain white matter
25. (Na+ + K+) Mg2+-ATPase of muscle plasma membranes in Duchenne muscular dystrophy
26. Infantile and juvenile spinal muscular atrophy
27. Studies of healthy relatives of patients with Duchenne muscular dystrophy
28. Kearns-Sayre Syndrome in Twins: Lethal Dominant Mutation or Acquired Disease?
29. Dysfunctional lamins as mediators of oxidative stress in Emery-Dreifuss muscular dystrophy.
30. Cardiovascular risk markers in dilated cardiomyopathy in Emery-Dreifuss muscular dystrophy (EDMD).
31. Tenascin-C in human cardiac pathology.
32. Circulating tenascin-C levels in patients with dilated cardiomyopathy in the course of Emery-Dreifuss muscular dystrophy.
33. Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods.
34. Matrix metalloproteinases in serum of Emery-Dreifuss muscular dystrophy patients.
35. Circulating autoantibodies to troponin I in Emery-Dreifuss muscular dystrophy.
36. Myelin composition of spinal cord in a model of amyotrophic lateral sclerosis (ALS) in SOD1G93A transgenic rats.
37. Evidence for autoimmunity to heart-specific antigens in patients with Emery-Dreifuss muscular dystrophy.
38. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS).
39. Expression of emerin and lamins in muscle of patients with different forms of Emery-Dreifuss muscular dystrophy.
40. Controversies about the function of dystrophin in muscle.
41. [Neurotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients against some enzymes of glutamate metabolism].
42. Identification of Gal(beta 1-3)GalNAc bearing glycoproteins in cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients.
43. Immunochemical quantification of glycoconjugates in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.
44. The influence of cysteine, reduced glutathione and 2-mercaptoethanol on creatine phosphokinase activity in muscular diseases.
45. [Cholesterol and fatty acid level in the blood serum in cases of apoplexy].
46. [Determination of the degree of hemoglobin oxidation by means of Pulfrich's photometer].
47. [Effect of cytochrome c on the alkali reserve level in acute carbon monoxide poisoning in guinea pigs].
48. Paraphenylene diamine oxidase activity in protein fractions of human and animal blood serum.
49. [THE LEVEL OF POTASSIUM IN DYSTROPHIC MUSCLES].
50. [Cerebrospinal fluid proteins in multiple sclerosis].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.